Sex disparities in acute myocardial infarction care and outcomes

We investigated sex‐based and regional outcomes after contemporary percutaneous coronary intervention (PCI) with the Xience V stent in patients with acute myocardial infarction (AMI).

[1]  S. Nuti,et al.  Are non-ST-segment elevation myocardial infarctions missing in China? , 2017, European heart journal. Quality of care & clinical outcomes.

[2]  K. Bønaa,et al.  Potential Implications of NORSTENT (Norwegian Coronary Stent Trial) in Contemporary Practice. , 2017, Circulation.

[3]  P. Serruys,et al.  Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration , 2017, JAMA cardiology.

[4]  Lechen Wang,et al.  Clinical characteristics and improvement of the guideline-based management of acute myocardial infarction in China: a national retrospective analysis , 2017, Oncotarget.

[5]  P. Austin,et al.  Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization , 2017, Journal of the American Heart Association.

[6]  M. Sabatine,et al.  The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. , 2016, American heart journal.

[7]  K. Tanabe,et al.  Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[8]  G. Stone,et al.  Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials). , 2016, The American journal of cardiology.

[9]  W. Shimizu,et al.  Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort , 2016, Heart and Vessels.

[10]  Kenta Ito,et al.  Clinical Characteristics of Patients With Acute Myocardial Infarction Who Did Not Undergo Primary Percutaneous Coronary Intervention- Report From the MIYAGI-AMI Registry Study. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[11]  W. Shimizu,et al.  Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era - Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) - . , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Harlan M Krumholz,et al.  ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data , 2015, The Lancet.

[13]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[14]  Neel M. Butala,et al.  Sex Differences in Long-Term Mortality After Myocardial Infarction: A Systematic Review , 2014, Circulation.

[15]  H. Suryapranata,et al.  First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients , 2014, Open Heart.

[16]  L. Kuller,et al.  Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women? , 2013, Journal of women's health.

[17]  D. McManus,et al.  Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study , 2013, Clinical epidemiology.

[18]  Takeshi Kimura,et al.  Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[19]  J. Messenger,et al.  Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. , 2012, Journal of the American College of Cardiology.

[20]  Mitchell W Krucoff,et al.  A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). , 2011, JACC. Cardiovascular interventions.

[21]  P. Serruys,et al.  Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. , 2011, European heart journal.

[22]  A. Yan,et al.  Factors influencing underutilization of evidence-based therapies in women. , 2011, European heart journal.

[23]  Ben He,et al.  Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from Shanghai Acute Coronary Event (SACE) Registry. , 2010, Chinese medical journal.

[24]  Sonia S. Anand,et al.  Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.

[25]  B. Gersh,et al.  Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.

[26]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[27]  C. Tei,et al.  Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[28]  Eric Peterson,et al.  The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes. , 2006, American heart journal.

[29]  H. Kasanuki,et al.  A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. , 2005, American heart journal.

[30]  D. Bell,et al.  Myocardial Infarction in Women: A Critical Appraisal of Gender Differences in Outcomes , 2000, Pharmacotherapy.

[31]  Takenoriyamaguchi.  Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation , 2000 .

[32]  C. Maynard,et al.  Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants. , 1999, The American journal of cardiology.

[33]  Harlan M. Krumholz,et al.  Sex-Based Differences in Early Mortality after Myocardial Infarction , 1999 .

[34]  B. Yan,et al.  Acute coronary syndrome in the Asia-Pacific region. , 2016, International journal of cardiology.

[35]  S. Saito,et al.  Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[36]  S. Saito,et al.  Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome , 2014 .

[37]  A. Kobori,et al.  Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[38]  [Guideline for diagnosis and treatment of patients with ST-elevation myocardial infarction]. , 2010, Zhonghua xin xue guan bing za zhi.

[39]  [Japanese Circulation Society (JCS) Joint Working Groups for Guidelines for Diagnosis and Treatment of Cardiovascular Diseases. Guidelines for the clinical application of echocardiography (JCS 2005)]. , 2006, Journal of cardiology.

[40]  G. Pasterkamp,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[41]  A. Jaffe,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. , 1988, Journal of the American College of Cardiology.